Journal of Clinical Endocrinology & Metabolism, Vol 81, 4075-4080, Copyright © 1996 by Endocrine Society

ARTICLES

X-linked hypophosphatemia: a search for gender, race, anticipation, or parent of origin effects on disease expression in children

MP Whyte, FW Schranck and R Armamento-Villareal
Metabolic Research Unit, Shriners Hospital for Crippled Children, St. Louis, Missouri 63131, USA.

X-Linked hypophosphatemia (XLH) is a sex-linked dominant disorder. It is possible that females are more mildly affected than males. No information is available regarding other potential genetic influences on XLH expression in patients, such as race, anticipation, parent of origin, or molecular heterogeneity. We investigated the above potential genetic influences on XLH expressivity using data from 116 pediatric patients. To compare biochemical parameters, we used data from the 30 prepubertal children (23 girls and 7 boys) selected because they had been without medical therapy for at least 3 months (25 of 30 never treated). To compare height z-scores, we used data from the 27 patients (pre- or postpubertal) selected because they had never received medical or surgical treatment. Ascertainment bias (i.e. referral of girls who were severely affected) was not apparent (observed female/male ratio, 1.64; expected, 2.00; P = 0.29). Parameters of mineral homeostasis did not show statistically significant differences between girls vs. boys, sporadic vs. multigenerational cases (except lower fasting serum phosphate levels in sporadic cases; mean +/- SEM, 2.68 +/- 0.10 vs. 3.02 +/- 0.04 mg/dL; P = 0.049), blacks vs. whites, or for the girls for whom affected fathers vs. mothers transmitted the disorder. Height z-scores correlated with renal phosphate reclamation (i.e. tubular maximum of phosphorus/glomerular filtration rate; r = 0.68; P = 0.014), but were not different for the groupings above. Furthermore, we found no evidence for meiotic drive or for a parental age effect to explain the 18.3% of patients that were new mutations for XLH. Our data fail to show any evidence for genetic heterogeneity or for gender, race, anticipation, or parent of origin effects on XLH expression in children. Despite the recent discovery of a gene (PEX) that is mutated in XLH, the sex-linked dominant phenotype and apparent absence of a gene dose effect in XLH expression in children require explanation.

This article has been cited by other articles:

				P. Makras, N. A. T. Hamdy, S. G. Kant, and S. E. Papapoulos Normal Growth and Muscle Dysfunction in X-Linked Hypophosphatemic Rickets Associated with a Novel Mutation in the PHEX Gene J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1386 - 1389. [Abstract] [Full Text] [PDF]

				K. Goji, K. Ozaki, A. H. Sadewa, H. Nishio, and M. Matsuo Somatic and Germline Mosaicism for a Mutation of the PHEX Gene Can Lead to Genetic Transmission of X-Linked Hypophosphatemic Rickets That Mimics an Autosomal Dominant Trait J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 365 - 370. [Abstract] [Full Text] [PDF]

				P. S.N. Rowe THE WRICKKENED PATHWAYS OF FGF23, MEPE AND PHEX Crit. Rev. Oral. Biol. Med., September 1, 2004; 15(5): 264 - 281. [Abstract] [Full Text] [PDF]

				A. J. Brewer, L. Canaff, G. N. Hendy, and H. S. Tenenhouse Differential regulation of PHEX expression in bone and parathyroid gland by chronic renal insufficiency and 1,25-dihydroxyvitamin D3 Am J Physiol Renal Physiol, April 1, 2004; 286(4): F739 - F748. [Abstract] [Full Text] [PDF]

				O. Makitie, A. Doria, S. W. Kooh, W. G. Cole, A. Daneman, and E. Sochett Early Treatment Improves Growth and Biochemical and Radiographic Outcome in X-Linked Hypophosphatemic Rickets J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3591 - 3597. [Abstract] [Full Text] [PDF]

				L. D. Quarles FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E1 - E9. [Abstract] [Full Text] [PDF]

				Y. Sabbagh, G. Boileau, M. Campos, A. K. Carmona, and H. S. Tenenhouse Structure and Function of Disease-Causing Missense Mutations in the PHEX Gene J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2213 - 2222. [Abstract] [Full Text] [PDF]

				J Singh, N Moghal, S H S Pearce, and T Cheetham The investigation of hypocalcaemia and rickets Arch. Dis. Child., May 1, 2003; 88(5): 403 - 407. [Abstract] [Full Text] [PDF]

				S. M. Jan De Beur and M. A. Levine Molecular Pathogenesis of Hypophosphatemic Rickets J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2467 - 2473. [Full Text] [PDF]

				P. T. Christie, B. Harding, M. A. Nesbit, M. P. Whyte, and R. V. Thakker X-Linked Hypophosphatemia Attributable to Pseudoexons of the PHEX Gene J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3840 - 3844. [Abstract] [Full Text] [PDF]

				I. A. Holm, A. E. Nelson, B. G. Robinson, R. S. Mason, D. J. Marsh, C. T. Cowell, and T. O. Carpenter Mutational Analysis and Genotype-Phenotype Correlation of the PHEX Gene in X-Linked Hypophosphatemic Rickets J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3889 - 3899. [Abstract] [Full Text] [PDF]

				P. H. Dixon, P. T. Christie, C. Wooding, D. Trump, M. Grieff, I. Holm, J. M. Gertner, J. Schmidtke, B. Shah, N. Shaw, et al. Mutational Analysis of PHEX Gene in X-Linked Hypophosphatemia J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3615 - 3623. [Abstract] [Full Text]

				M. J. Econs and F. Francis Positional cloning of the PEX gene: new insights into the pathophysiology of X-linked hypophosphatemic rickets Am J Physiol Renal Physiol, October 1, 1997; 273(4): F489 - F498. [Abstract] [Full Text] [PDF]

				F. Francis, T. M. Strom, S. Hennig, A. Boddrich, B. Lorenz, O. Brandau, K. L. Mohnike, M. Cagnoli, C. Steffens, S. Klages, et al. Genomic Organization of the Human PEX Gene Mutated in X-Linked Dominant Hypophosphatemic Rickets Genome Res., June 1, 1997; 7(6): 573 - 585. [Abstract] [Full Text] [PDF]